The IQCB1 gene gives instructions for a protein that helps tiny antenna-like structures in kidney and eye cells work properly. This gene plays an important role in how these cells sense signals and stay healthy. If the gene does not work, some people develop a genetic condition that can lead to gradual kidney damage, often causing nephronophthisis, along with vision loss from retinal disease. Pathogenic variants in the IQCB1 gene are a known cause of Senior-Løken syndrome.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes hold the directions for producing proteins, the parts of cells that do much of the work. Other genes mainly help determine when certain processes happen, where they occur, and how strongly they operate. Taken together, genes influence how the body develops and functions, and they can affect how you respond to food, stress, or medications. To explore this subject in greater detail, you can find more in the LearnHub.
Overview
IQCB1Gene function
What if the gene works
Your cells use the IQCB1 gene to help cilia work properly. These tiny cell structures are especially important in the retina and kidneys, where they support light sensing and normal kidney tubule function.
Risk
What if the gene does not work
Variants in the IQCB1 gene can cause kidney disease and early retinal disease that affects sight. Milder and more severe variants can influence when problems begin and how strongly the kidneys and eyes are affected.
Treatment
What does that mean for your treatment
No gene-specific treatment or drug-selection approach is currently established for pathogenic or loss-of-function variants in the IQCB1 gene; treatment is based on the usual management of the kidney and eye features a person develops, rather than on an IQCB1-directed medicine.
Conditions associated with IQCB1
Gene function
What if the gene works
In many cells, the IQCB1 gene helps tiny hair-like structures called cilia do their routine jobs. Cilia act like antennae, helping cells sense their surroundings and move key materials. This helps explain how the IQCB1 gene supports cilia in the kidney and retina.
The IQCB1 gene helps build and steady cilia, which are tiny antenna-like parts on the cell surface. These structures let cells sense signals from their surroundings and coordinate routine cell activity.
Inside cilia, the IQCB1 gene helps proteins reach the right place at the right time. This organized transport supports smooth communication between the cell body and the tip of the cilium.
In the retina, the IQCB1 gene supports the narrow bridge that moves materials within light-sensing cells. This daily flow helps photoreceptor cells refresh the parts they use to capture light.
In kidney tubule cells, the IQCB1 gene supports cilia that detect fluid flow. This helps cells adjust everyday signals that guide tubule structure and routine kidney work.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the IQCB1 gene create a shortened, unstable protein or stop it from being made, so cells cannot maintain small projections called cilia normally. Some variants still produce the protein but change its shape or weaken its links with other cilia proteins, leaving partial activity. This range helps explain how variants in the IQCB1 gene affect protein function, with more disruptive changes often linked to earlier or broader kidney and eye involvement than milder variants.
How variants are linked to conditions
Pathogenic variants in the IQCB1 gene are a well-established cause of Senior-Løken syndrome, often described as the IQCB1 gene and Senior-Løken syndrome link in genetic testing reports. This condition combines a kidney disease called nephronophthisis, which can lead to worsening kidney function in childhood or adolescence, with early retinal disease that affects vision. In some people, the eye findings may resemble Leber congenital amaurosis or another severe inherited retinal condition.
A variant is not necessarily a diagnosis
Genetic variants are common and are a normal feature of human biology. Most do not directly affect health and simply contribute to the natural diversity seen among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. Still, in some situations, one well-studied variant in a particular gene is enough to confirm the diagnosis.
Are there things that can increase or change my risk?
For IQCB1-related conditions, risk is mainly set by genetics rather than lifestyle. A child’s risk is higher when both biological parents carry a harmful IQCB1 change, while for someone who already has two nonworking copies, there is not enough evidence to say that diet, exercise, or other everyday factors lower the chance of developing the condition.
Inheritance of IQCB1 variants
Variants in the IQCB1 gene are inherited in an autosomal recessive pattern. In practical terms, this means a child usually inherits one nonworking copy from each parent. When both parents carry one IQCB1 gene variant, each pregnancy has a 25% chance of the child inheriting both variants, a 50% chance of being a carrier like the parents, and a 25% chance of inheriting neither variant. This explains how IQCB1 gene inheritance typically works in families affected by IQCB1 related conditions.
What does my IQCB1 result mean for my family?
For families with an IQCB1-related condition, the pattern is usually recessive, which means parents are often healthy carriers and brothers or sisters may also be carriers or, less often, have the condition. Close relatives may want to learn whether they carry the same gene change, especially when planning a family. Children of someone with an IQCB1-related condition will usually be carriers unless the other parent also carries an IQCB1 change.
Genetic information
Genetic testing
How you find out about variants
IQCB1 genetic testing usually uses a blood or saliva sample to read the IQCB1 gene and look for variants. It may be part of a kidney disease or inherited retinal disease panel, or included in broader exome or genome testing. Results can show whether two disease causing variants are present and help confirm a genetic diagnosis.
When should I consider getting a genetic test?
Consider testing the IQCB1 gene if someone has a combination of progressive kidney disease and vision loss that started in childhood, or a family history of this pattern. Testing can help confirm an inherited cause and clarify whether close relatives may also carry the change.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and on the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This is common and can help explain why the same medication works well for one person, seems less effective for another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics studies how genetic differences shape the way people respond to medications. It examines links between genes and drugs to help explain why the same treatment may work differently from one person to another. With many medicines, genes affect both how strongly a drug works and how the body processes it. This information can support more informed and more individualized treatment decisions. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the IQCB1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used, so any questions about treatment, side effects, or changes in your medicines are best discussed with your doctor.
History
The IQCB1 gene entered medical genetics in the early 2000s during studies of families affected by kidney disease and vision loss that appeared together in the same inherited condition. Researchers first reported it under the name NPHP5, linking changes in this gene to Senior-Løken syndrome, a condition combining nephronophthisis with retinal degeneration. From these first observations, research expanded steadily. As more families were studied, IQCB1 became part of a broader shift in understanding so called ciliopathies, a group of inherited conditions tied to problems in tiny cell structures called cilia. This work helped connect earlier clinical descriptions with a clearer genetic explanation and shaped modern testing for related conditions.